Suppr超能文献

瘦素通过Src家族激酶介导的、不依赖于janus激酶2的途径诱导雌激素受体阴性乳腺癌中鞘氨醇激酶1的上调。

Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway.

作者信息

Alshaker Heba, Krell Jonathan, Frampton Adam E, Waxman Jonathan, Blyuss Oleg, Zaikin Alexey, Winkler Mathias, Stebbing Justin, Yagüe Ernesto, Pchejetski Dmitri

出版信息

Breast Cancer Res. 2014 Oct 25;16(5):426. doi: 10.1186/s13058-014-0426-6.

Abstract

INTRODUCTION

Obesity is a known risk factor for breast cancer. Sphingosine kinase 1 (SK1) is an oncogenic lipid kinase that is overexpressed in breast tumours and linked with poor prognosis, however, its role in obesity-driven breast cancer was never elucidated.

METHODS

Human primary and secondary breast cancer tissues were analysed for SK1 and leptin receptor expression using quantitative real-time polymerase chain reaction (qRT-PCR) assay. Leptin-induced signalling was analysed in human oestrogen receptor (ER)-positive and negative breast cancer cells using Western blotting, qRT-PCR and radiolabelling assays.

RESULTS

Our findings show for the first time that human primary breast tumours and associated lymph node metastases exhibit a strong correlation between SK1 and leptin receptor expression (Pearson R = 0.78 and R = 0.77, respectively, P <0.001). Both these genes are elevated in metastases of ER-negative patients and show a significant increase in patients with higher body mass index (BMI). Leptin induces SK1 expression and activation in ER-negative breast cancer cell lines MDAMB-231 and BT-549, but not in ER-positive cell lines. Pharmacological inhibition and gene knockdown showed that leptin-induced SK1 activity and expression are mediated by activation of extracellular signal-regulated kinases 1/2 (ERK1/2) and Src family kinase (SFK) pathways, but not by the major pathways downstream of leptin receptor (LEPR) - janus kinase 2 (JAK2) and signal transducer and activator of transcription 3 (STAT3). Src-homology 2 domain-containing phosphatase 2 (SHP2) appeared to be key to SK1 activation, and may function as an adaptor protein between SFKs and LEPR. Importantly, leptin-induced breast cancer cell proliferation was abrogated by SK1-specific small interfering RNA (siRNA).

CONCLUSIONS

Overall, our findings demonstrate a novel SFK/ERK1/2-mediated pathway that links leptin signalling and expression of oncogenic enzyme SK1 in breast tumours and suggest the potential significance of this pathway in ER-negative breast cancer.

摘要

引言

肥胖是已知的乳腺癌风险因素。鞘氨醇激酶1(SK1)是一种致癌脂质激酶,在乳腺肿瘤中过度表达且与预后不良相关,然而,其在肥胖驱动的乳腺癌中的作用从未得到阐明。

方法

使用定量实时聚合酶链反应(qRT-PCR)分析人原发性和继发性乳腺癌组织中SK1和瘦素受体的表达。使用蛋白质免疫印迹、qRT-PCR和放射性标记分析在人雌激素受体(ER)阳性和阴性乳腺癌细胞中瘦素诱导的信号传导。

结果

我们的研究结果首次表明,人原发性乳腺肿瘤及相关淋巴结转移灶中SK1和瘦素受体表达之间存在强相关性(Pearson相关系数分别为R = 0.78和R = 0.77,P <0.001)。这两个基因在ER阴性患者的转移灶中升高,且在体重指数(BMI)较高的患者中显著增加。瘦素诱导ER阴性乳腺癌细胞系MDAMB - 231和BT - 549中SK1的表达和激活,但在ER阳性细胞系中则不然。药理学抑制和基因敲低表明,瘦素诱导的SK1活性和表达是由细胞外信号调节激酶1/2(ERK1/2)和Src家族激酶(SFK)途径的激活介导的,而非由瘦素受体(LEPR)下游的主要途径——janus激酶2(JAK2)和信号转导及转录激活因子3(STAT3)介导。含Src同源2结构域的磷酸酶2(SHP2)似乎是SK1激活的关键,并且可能作为SFK和LEPR之间的衔接蛋白发挥作用。重要的是,瘦素诱导的乳腺癌细胞增殖被SK1特异性小干扰RNA(siRNA)消除。

结论

总体而言,我们的研究结果证明了一种新的SFK/ERK1/2介导的途径,该途径将瘦素信号传导与乳腺肿瘤中致癌酶SK1的表达联系起来,并提示该途径在ER阴性乳腺癌中的潜在重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b8/4303110/7819a9b46693/13058_2014_426_Fig1_HTML.jpg

相似文献

4
Leptin stimulates both JAK2-dependent and JAK2-independent signaling pathways.
J Biol Chem. 2008 Oct 17;283(42):28066-73. doi: 10.1074/jbc.M805545200. Epub 2008 Aug 21.
10
Downregulation of microRNA-515-5p by the estrogen receptor modulates sphingosine kinase 1 and breast cancer cell proliferation.
Cancer Res. 2013 Oct 1;73(19):5936-48. doi: 10.1158/0008-5472.CAN-13-0158. Epub 2013 Aug 8.

引用本文的文献

1
Obesity-cancer axis crosstalk: Molecular insights and therapeutic approaches.
Acta Pharm Sin B. 2025 Jun;15(6):2930-2944. doi: 10.1016/j.apsb.2025.04.029. Epub 2025 May 5.
3
Machine learning approaches for predicting 5-year breast cancer survival: A multicenter study.
Cancer Sci. 2023 Oct;114(10):4063-4072. doi: 10.1111/cas.15917. Epub 2023 Jul 25.
4
The Head-to-Toe Hormone: Leptin as an Extensive Modulator of Physiologic Systems.
Int J Mol Sci. 2022 May 13;23(10):5439. doi: 10.3390/ijms23105439.
5
Sphingosine Kinase 1 Signaling in Breast Cancer: A Potential Target to Tackle Breast Cancer Stem Cells.
Front Mol Biosci. 2021 Nov 8;8:748470. doi: 10.3389/fmolb.2021.748470. eCollection 2021.
6
The Adipokine Component in the Molecular Regulation of Cancer Cell Survival, Proliferation and Metastasis.
Pathol Oncol Res. 2021 Sep 13;27:1609828. doi: 10.3389/pore.2021.1609828. eCollection 2021.
7
Obesity and Cancer Metastasis: Molecular and Translational Perspectives.
Cancers (Basel). 2020 Dec 16;12(12):3798. doi: 10.3390/cancers12123798.
8
The Tumorigenic Effect of Sphingosine Kinase 1 and Its Potential Therapeutic Target.
Cancer Control. 2020 Jan-Dec;27(1):1073274820976664. doi: 10.1177/1073274820976664.
9
A Variant of Gene Decreases the Risk of Gastric Cancer in Chinese Individuals: Evidence from a Case-Control Study.
Pharmgenomics Pers Med. 2020 Sep 22;13:397-404. doi: 10.2147/PGPM.S258672. eCollection 2020.
10
Sphingosine Kinase 1 in Breast Cancer-A New Molecular Marker and a Therapy Target.
Front Oncol. 2020 Mar 20;10:289. doi: 10.3389/fonc.2020.00289. eCollection 2020.

本文引用的文献

1
Leptin receptor maintains cancer stem-like properties in triple negative breast cancer cells.
Endocr Relat Cancer. 2013 Oct 14;20(6):797-808. doi: 10.1530/ERC-13-0329. Print 2013 Dec.
3
Therapeutic potential of targeting SK1 in human cancers.
Adv Cancer Res. 2013;117:143-200. doi: 10.1016/B978-0-12-394274-6.00006-6.
4
Sphingosine kinase isoforms as a therapeutic target in endocrine therapy resistant luminal and basal-A breast cancer.
Exp Biol Med (Maywood). 2012 Jul;237(7):832-44. doi: 10.1258/ebm.2012.012028. Epub 2012 Aug 2.
7
Obesity and the risk for premenopausal and postmenopausal breast cancer.
Cancer Prev Res (Phila). 2012 Apr;5(4):515-21. doi: 10.1158/1940-6207.CAPR-12-0091. Epub 2012 Mar 5.
10
The multifactorial role of leptin in driving the breast cancer microenvironment.
Nat Rev Endocrinol. 2011 Nov 15;8(5):263-75. doi: 10.1038/nrendo.2011.184.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验